Pathfinder Therapeutics, Inc. (PTI) is the developer of ExplorerTM, an image-guided surgery device that enables physicians to accurately and efficiently guide the delivery of cancer therapeutics (usually resection and/or ablation) in soft-tissue organs.
ExplorerTM is the first medical device cleared by the FDA in the category of Intraoperative Soft Tissue Tracking. ScoutTM, our advanced 3D planning software, provides highly detailed visual and volumetric information for preoperative assessment, thus enabling clinicians to visualize the site of disease, plan the resection and/or ablation and monitor the resultant effects. Read More>